Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:42:02.725Z.
Calculation as of: 2026-10-06T14:42:02.725Z.
Quote observation: 2026-10-06T14:40:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1c66db039e427230ae26789b54a30ba38da86a4a62527efc47f68a44edb52430
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-17.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Monte Rosa Therapeutics, Inc.
Market Cap
$841.42M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$862.71M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885.96M
EV/EBITDA Ratio
5.91x
TTM Avg
5.93x
3Y Avg
5.93x
5Y Avg
5.93x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | $841.42M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $834.78M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $825.76M | N/A | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $862.71M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $819.78M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $807.22M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.85M | 5.93x | 7.11x | 8.26x | 13.78x |
| Ardelyx, Inc. (ARDX)vs › | $804.28M | N/A | 7.99x | 7.99x | 7.99x |
| Arbutus Biopharma Corp (ABUS)vs › | $885.96M | 5.91x | 5.93x | 5.93x | 5.93x |
| AdaptHealth Corp. (AHCO)vs › | $789.11M | 6.64x | 5.45x | 14.30x | 12.03x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-03-17 | 48.83x |
| 2026-03-16 | 50.01x |
| 2026-03-13 | 48.79x |
| 2026-03-12 | 48.87x |
| 2026-03-11 | 52.61x |
| 2026-03-10 | 53.42x |
| 2026-03-09 | 54.81x |
| 2026-03-06 | 55.33x |
| 2026-03-05 | 55.88x |
| 2026-03-04 | 58.30x |
| 2026-03-03 | 55.91x |
| 2026-03-02 | 57.89x |
| 2026-02-27 | 55.14x |
| 2026-02-26 | 57.89x |
| 2026-02-25 | 56.39x |
| 2026-02-24 | 60.50x |
| 2026-02-23 | 61.60x |
| 2026-02-20 | 59.66x |
| 2026-02-19 | 60.32x |
| 2026-02-18 | 57.09x |
| 2026-02-17 | 57.38x |
| 2026-02-13 | 55.77x |
| 2026-02-12 | 57.89x |
| 2026-02-11 | 59.58x |
| 2026-02-10 | 61.82x |
| 2026-02-09 | 61.89x |
| 2026-02-06 | 61.75x |
| 2026-02-05 | 59.36x |
| 2026-02-04 | 61.67x |
| 2026-02-03 | 66.81x |
| 2026-02-02 | 66.63x |
| 2026-01-30 | 65.31x |
| 2026-01-29 | 68.39x |
| 2026-01-28 | 67.54x |
| 2026-01-27 | 74.77x |
| 2026-01-26 | 72.17x |
| 2026-01-23 | 73.82x |
| 2026-01-22 | 74.48x |
| 2026-01-21 | 78.92x |
| 2026-01-20 | 79.69x |
| 2026-01-16 | 77.01x |
| 2026-01-15 | 78.37x |
| 2026-01-14 | 78.30x |
| 2026-01-13 | 78.04x |
| 2026-01-12 | 77.05x |
| 2026-01-09 | 79.10x |
| 2026-01-08 | 82.88x |
| 2026-01-07 | 75.43x |
| 2026-01-06 | 48.76x |
| 2026-01-05 | 42.85x |
| 2026-01-02 | 46.19x |
| 2025-12-31 | 47.55x |
| 2025-12-30 | 48.61x |
| 2025-12-29 | 49.16x |
| 2025-12-26 | 53.45x |
| 2025-12-24 | 54.74x |
| 2025-12-23 | 50.48x |
| 2025-12-22 | 49.42x |
| 2025-12-19 | 47.03x |
| 2025-12-18 | 48.10x |
| 2025-12-17 | 51.47x |
| 2025-12-16 | 58.48x |
| 2025-12-15 | 50.37x |
| 2025-12-12 | 49.86x |
| 2025-12-11 | 50.78x |
| 2025-12-10 | 53.23x |
| 2025-12-09 | 52.35x |
| 2025-12-08 | 55.51x |
| 2025-12-05 | 53.90x |
| 2025-12-04 | 53.34x |
| 2025-12-03 | 51.88x |
| 2025-12-02 | 46.56x |
| 2025-12-01 | 47.91x |
| 2025-11-28 | 49.35x |
| 2025-11-26 | 48.68x |
| 2025-11-25 | 48.79x |
| 2025-11-24 | 47.84x |
| 2025-11-21 | 42.19x |
| 2025-11-20 | 39.62x |
| 2025-11-19 | 41.90x |
| 2025-11-18 | 40.58x |
| 2025-11-17 | 39.95x |
| 2025-11-14 | 42.70x |
| 2025-11-13 | 42.56x |
| 2025-11-12 | 41.97x |
| 2025-11-11 | 42.56x |
| 2025-11-10 | 41.60x |
| 2025-11-07 | 35.18x |
| 2025-11-06 | 33.25x |
| 2025-11-05 | 31.40x |
| 2025-11-04 | 30.58x |
| 2025-11-03 | 30.76x |
| 2025-10-31 | 32.83x |
| 2025-10-30 | 33.25x |
| 2025-10-29 | 31.90x |
| 2025-10-28 | 31.72x |
| 2025-10-27 | 31.42x |
| 2025-10-24 | 28.30x |
| 2025-10-23 | 26.28x |
| 2025-10-22 | 23.56x |
| 2025-10-21 | 24.19x |
| 2025-10-20 | 24.93x |
| 2025-10-17 | 25.41x |
| 2025-10-16 | 26.10x |
| 2025-10-15 | 28.22x |
| 2025-10-14 | 26.89x |
| 2025-10-13 | 26.34x |
| 2025-10-10 | 25.38x |
| 2025-10-09 | 21.20x |
| 2025-10-08 | 19.21x |
| 2025-10-07 | 18.34x |
| 2025-10-06 | 19.08x |
| 2025-10-03 | 19.29x |
| 2025-10-02 | 19.00x |
| 2025-10-01 | 18.65x |
| 2025-09-30 | 18.42x |
| 2025-09-29 | 18.15x |
| 2025-09-26 | 18.63x |
| 2025-09-25 | 16.14x |
| 2025-09-24 | 16.32x |
| 2025-09-23 | 15.56x |
| 2025-09-22 | 16.09x |
| 2025-09-19 | 15.56x |
| 2025-09-18 | 17.14x |
| 2025-09-17 | 15.63x |
| 2025-09-16 | 15.93x |
| 2025-09-15 | 17.14x |
| 2025-09-12 | 11.53x |
| 2025-09-11 | 11.74x |
| 2025-09-10 | 11.50x |
| 2025-09-09 | 11.58x |
| 2025-09-08 | 11.50x |
| 2025-09-05 | 11.87x |
| 2025-09-04 | 11.79x |
| 2025-09-03 | 12.03x |
| 2025-09-02 | 11.82x |
| 2025-08-29 | 11.50x |
| 2025-08-28 | 11.58x |
| 2025-08-27 | 11.16x |
| 2025-08-26 | 11.16x |
| 2025-08-25 | 10.95x |
| 2025-08-22 | 11.55x |
| 2025-08-21 | 10.71x |
| 2025-08-20 | 10.52x |
| 2025-08-19 | 10.44x |
| 2025-08-18 | 10.87x |
| 2025-08-15 | 10.92x |
| 2025-08-14 | 10.31x |
| 2025-08-13 | 10.55x |
| 2025-08-12 | 10.57x |
| 2025-08-11 | 9.89x |
| 2025-08-08 | 10.39x |
| 2025-08-07 | 51.15x |
| 2025-08-06 | 52.91x |
| 2025-08-05 | 59.26x |
| 2025-08-04 | 59.93x |
| 2025-08-01 | 58.72x |
| 2025-07-31 | 60.88x |
| 2025-07-30 | 69.38x |
| 2025-07-29 | 65.06x |
| 2025-07-28 | 68.98x |
| 2025-07-25 | 70.60x |
| 2025-07-24 | 71.14x |
| 2025-07-23 | 74.52x |
| 2025-07-22 | 70.47x |
| 2025-07-21 | 72.76x |
| 2025-07-18 | 74.25x |
| 2025-07-17 | 73.71x |
| 2025-07-16 | 69.79x |
| 2025-07-15 | 64.66x |
| 2025-07-14 | 65.06x |
| 2025-07-11 | 63.71x |
| 2025-07-10 | 65.06x |
| 2025-07-09 | 65.47x |
| 2025-07-08 | 62.36x |
| 2025-07-07 | 61.15x |
| 2025-07-03 | 59.80x |
| 2025-07-02 | 57.91x |
| 2025-07-01 | 56.29x |
| 2025-06-30 | 54.94x |
| 2025-06-27 | 56.15x |
| 2025-06-26 | 56.96x |
| 2025-06-25 | 58.45x |
| 2025-06-24 | 58.04x |
| 2025-06-23 | 56.69x |
| 2025-06-20 | 56.56x |
| 2025-06-18 | 54.67x |
| 2025-06-17 | 55.75x |
| 2025-06-16 | 59.12x |
| 2025-06-13 | 60.34x |
| 2025-06-12 | 60.47x |
| 2025-06-11 | 62.23x |
| 2025-06-10 | 62.63x |
| 2025-06-09 | 60.47x |
| 2025-06-06 | 61.69x |
| 2025-06-05 | 56.42x |
| 2025-06-04 | 56.29x |
| 2025-06-03 | 56.69x |
| 2025-06-02 | 54.80x |
| 2025-05-30 | 50.48x |
| 2025-05-29 | 51.15x |
| 2025-05-28 | 48.86x |
| 2025-05-27 | 47.91x |
| 2025-05-23 | 47.64x |
| 2025-05-22 | 48.72x |
| 2025-05-21 | 48.18x |
| 2025-05-20 | 50.21x |
| 2025-05-19 | 49.53x |
| 2025-05-16 | 47.78x |
| 2025-05-15 | 46.29x |
| 2025-05-14 | 44.00x |
| 2025-05-13 | 48.59x |
| 2025-05-12 | 51.69x |
| 2025-05-09 | 49.26x |
